Nasdaq Turns Higher; Akumin Shares Jump

U.S. stocks pared losses midway through trading, with the Nasdaq Composite gaining over 60 points on Monday. The Dow traded down 0.01% to 33,126.50 while the NASDAQ rose 0.54% to 13,054.00. The S&P 500 also rose, gaining, 0.29% to 4,236.55.

U.S. stocks pared losses midway through trading, with the Nasdaq Composite gaining over 60 points on Monday.

The Dow traded down 0.01% to 33,126.50 while the NASDAQ rose 0.54% to 13,054.00. The S&P 500 also rose, gaining, 0.29% to 4,236.55.

Check This Out: This Analyst With 85% Accuracy Rate Sees More Than 42% Upside In Amazon.com – Here Are 5 Stock Picks For Last Week From Wall Street’s Most Accurate Analysts

 

Leading and Lagging Sectors

 

Communication services shares rose by 0.9% on Monday.

In trading on Monday, energy shares dipped by 1%.

 

Top Headline

 

The Chicago Fed National Activity Index climbed to +0.02 in September versus a revised reading of -0.22 in the prior month.

 

Equities Trading UP

 

LumiraDx Limited (NASDAQ:LMDX) shares shot up 205% to $0.2650 after the company reported a strategic collaboration with AstraZeneca and Everton in the Community to set up England’s first community-based heart and lung screening hub.

Shares of INVO Bioscience, Inc. (NASDAQ:INVO) got a boost, shooting 337% to $2.36 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.

Akumin Inc. (NASDAQ:AKU) shares were also up, gaining 154% to $0.3703 after the company reached an agreement with Stonepeak to become a private company.

 

Equities Trading DOWN

 

Li-Cycle Holdings Corp. (NYSE:LICY) shares dropped 42% to $1.3082 after the company announced plans to halt construction work on its Rochester Hub project, pending completion of a comprehensive review of the go-forward strategy for the project..

Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) were down 43% to $16.00 after the company announced it presented clinical activity and safety data from its Phase 1/1b trial of RMC-6236.

Apollomics, Inc. (NASDAQ:APLM) was down, falling 40% to $1.04 after the company announced the presentation of vebreltinib efficacy and safety data from the KUNPENG clinical trial at ESMO 2023.

Also Check This Out: Top 4 Consumer Stocks That May Crash This Quarter

 

Commodities

 

In commodity news, oil traded down 2% to $86.39 while gold traded down 0.3% at $1,988.50.

Silver traded down 1.2% to $23.225 on Monday while copper rose 0.4% to $3.5765.

 

Euro zone

 

European shares were mixed today. The eurozone’s STOXX 600 fell 0.12%, London’s FTSE 100 fell 0.36% while Spain’s IBEX 35 Index fell 0.41% The German DAX fell 0.03% French CAC 40 rose 0.51%, while Italy’s FTSE MIB Index gained 0.80%.

 

Asia Pacific Markets

 

Asian markets closed lower on Monday, with Japan’s Nikkei 225 falling 0.83% and China’s Shanghai Composite Index falling 1.47%. India’s S&P BSE Sensex, meanwhile, fell 0.8%.

Food prices in Singapore rose by 4.3% year-over-year in September following a 4.8% increase in August. Singapore’s annual inflation rate rose to 4.1% in September from August’s level of 4.0%.

 

Economics

 

The Chicago Fed National Activity Index climbed to +0.02 in September versus a revised reading of -0.22 in the prior month.

Now Read This: $15M Bet On Day One Biopharmaceuticals? Check Out These 3 Stocks Insiders Are Buying

Total
0
Shares
Related Posts
Read More

This Analyst With 90% Accuracy Rate Raises PT On Chesapeake Energy; Here Are 5 Stock Picks For Last Week From Benzinga’s Most Accurate Analysts

Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst's opinion to trust.

CHK